Get Live Data

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Scancell Holdings Share Price
  4. Scancell Holdings Share Regulatory News
  5. Annual Financial Report

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Scancell Holdings Information

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
19.50    -1.50 (-7.32%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £197.18m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Annual Financial Report

10 Jul 2013 10:55

RNS Number : 0084J
Scancell Holdings Plc
10 July 2013
Β 

ο»Ώ

Scancell Holdings plc

("Scancell" or the "Company")

Β 

Annual Report and Accounts

Β 

The Company announces that its annual report and accounts for the financial year ended 30 April 2013 have been posted to shareholders of the Company and a copy is available on the Company's website: www.scancell.co.uk

For Further Information:

Β 

Dr Richard Goodfellow, Joint CEO

Professor Lindy Durrant, Joint CEO

Scancell Holdings Plc

Scancell Holdings Plc

+ 44 (0) 74 2323 0497Β 

+ 44 (0) 74 2323 0497Β 

Β 

Simon Conway/Mo Noonan

FTI Consulting

+44 (0) 20 7831 3113

Camilla Hume/Stephen Keys

Cenkos Securities plc

+ 44 (0) 20 7397 8900

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACSGCGDRSUBBGXG
12345678910
Date   Source Headline
28th Apr 20267:00 amRNSFDA Fast Track Designation for iSCIB1+
2nd Apr 20267:00 amRNSScancell announces CFO transition
29th Jan 20267:00 amRNSHalf-year Financial Report
26th Jan 20267:00 amRNSFDA clearance of IND application for iSCIB1+
22nd Jan 20267:00 amRNSNotice of Results
9th Dec 20257:00 amRNSContinued improvement in PFS with iSCIB1+
7th Nov 20257:00 amRNSResearch Update
30th Oct 20253:30 pmRNSResult of AGM
3rd Oct 20257:00 amRNSNotice of AGM
16th Sep 20257:00 amRNSDirector Dealing
11th Sep 20257:00 amRNSFinal Results
4th Sep 20257:00 amRNSNotice of Results
8th Aug 202512:31 pmRNSDirector Dealing
4th Aug 202510:23 amRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSStrong Phase 2 data on iSCIB1+ in Melanoma
16th Jul 20257:00 amRNSShare Option Exercise
25th Jun 20257:00 amRNSScancell initiates new arm in SCOPE Phase 2 study
21st May 20257:00 amRNSDirector Dealing
14th Apr 20257:00 amRNSPartnership with NHS Cancer Vaccine Launch Pad
1st Apr 20257:00 amRNSScancell to present at 2025 AACR Annual Meeting
20th Feb 20257:00 amRNSIssue of share options
17th Feb 20257:00 amRNSScancell presenting at AACR IO conference
30th Jan 20257:00 amRNSInterim Results
23rd Jan 20257:00 amRNSNotice of Interim Results
9th Jan 20257:00 amRNSModi-1 Vaccine Achieves Early Clinical Validation
9th Dec 202411:41 amRNSResult of Retail Offer and Total Voting Rights
5th Dec 202412:39 pmRNSResult of Placing and Subscription
4th Dec 20246:03 pmRNSRetail Offer for up to £1 million
4th Dec 20245:59 pmRNSProposed fundraise in excess of £8.5 million
4th Dec 20247:00 amRNSSecond Commercial License Agreement with Genmab
18th Nov 20247:00 amRNSPositive data from Phase 2 SCOPE trial with SCIB1
25th Oct 20243:26 pmRNSResult of Annual General Meeting
24th Oct 20247:00 amRNSHolding(s) in Company
22nd Oct 20247:00 amRNSScancell Appoints Dr Phil L’Huillier as CEO
1st Oct 20247:00 amRNSNotice of AGM
24th Sep 20247:00 amRNSResults Year Ended 30 April 2024
18th Sep 20247:00 amRNSNotice of Final Results
17th Sep 20247:00 amRNSStrategic Partnership with PharmaJet
2nd Sep 20247:00 amRNSScancell to attend upcoming conferences
30th Jul 20247:17 amRNSScancell Appoints Dr Nermeen Varawalla as CMO
30th Jul 20247:00 amRNSScancell Appoints Dr Nermeen Varawalla as CMO
24th Jul 20247:00 amRNSUpdate from iSCIB1+ Clinical Advisory Meeting
10th Jul 20247:00 amRNSAppointment of Dr Florian Reinaud to the Board
2nd Jul 20247:00 amRNSExtension of Convertible Loan Notes
1st Jul 20247:00 amRNSBlock Listing Return and Total Voting Rights
21st Jun 20247:00 amRNSChange of Nominated Advisor
12th Jun 20247:32 amRNSAgreement with major biotech
31st May 20247:00 amRNSScancell to attend upcoming conferences
30th May 20247:00 amRNSUpdate on ModiFY trial
24th May 20247:00 amRNSScancell to present at ASCO Annual Meeting
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SHG
SHG.L
LSE
0.00%
BHI
BHI.L
LSE
0.00%
ORCA
Orcadian Engy
LSE
0.00%
EGI
EGI.L
LSE
0.00%
GAID
Gail(india)gdr
LSE
-3.46%
Trending
RRR
Red Rock Resources
LSE
-4.17%
MAC
Marechale Cap.
LSE
3.70%
PREM
Premier African Minerals
LSE
0.00%
FORG
Forgent
LSE
-7.10%
ZEN
Zenith Energy
LSE
-5.00%